Omeprazole And Sodium Bicarbonate Powder, For Suspension
Pricing Report NDC 68682-990-30

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends

Current Package Pricing Information

The latest wholesale acquisition cost for Omeprazole And Sodium Bicarbonate (NDC 68682-990-30) is $7.04898 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Sep 17, 2025.

As a a human prescription drug provided by Oceanside Pharmaceuticals, this medication is distributed in a 30 PACKET in 1 CARTON / 1 POWDER, FOR SUSPENSION in 1 PACKET configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$7.04898
Per EA

Effective Date
Sep 17, 2025
Data Status
As of Oct 01, 2025
C/I - Chain or Independent Pharmacy
Package NDC
Description
30 PACKET in 1 CARTON / 1 POWDER, FOR SUSPENSION in 1 PACKET
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Sep 2020, the NADAC wholesale price for (NDC ) has moved within a range of $7.04898 to $18.32272 per EA. Over this 4 years and 11 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$7.0490 - $18.3227
Market Volatility
159.93% Variance
Latest Trend
2.77%
Date Unit Price Unit Source Method Rate
Sep 17, 2025 $7.04898 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 20, 2025 $7.24961 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 23, 2025 $7.48445 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 18, 2025 $7.80958 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 21, 2025 $8.59434 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 23, 2025 $9.32020 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 19, 2025 $10.14972 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 19, 2025 $10.18178 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 22, 2025 $10.18680 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 18, 2024 $10.05082 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 20, 2024 $9.88035 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 23, 2024 $10.04952 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 18, 2024 $10.33050 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 21, 2024 $11.44423 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 17, 2024 $12.02493 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 19, 2024 $14.68370 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 22, 2024 $16.37481 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 17, 2024 $18.32272 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 23, 2020 $12.89160 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 23, 2020 $12.89160 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026